Gland Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-11-17 ms6000000536352595 来自四川省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：甲状腺
经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-01-27 1e1d9025m73(暂无匿称)

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0
偏重的研究方向：乳腺;甲状腺
经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！

84 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-11-01 tangshicong

审稿速度:2.0 | 投稿命中率:75.0
经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。

60 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-08-08 ms1000000019437335

请问接收后多久能见刊啊

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-05-12 ms3000001761424859

偏重的研究方向：甲状腺
经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃

52 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-09-16 14744327m60暂无昵称

审稿前要求提交单位介绍信，请问一定要单位介绍信么？

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-11-01 tangshicong

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0
偏重的研究方向：临床;回顾性研究
经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。

82 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-11-05 taoyuan2714

投稿命中率:50.0
经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-07-27 documenta r y

7天了还awaiting assignment，这个一般多久决定送不送外审啊

53 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169187, encodeId=f8d4216918ec2, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：甲状腺 经验分享：请问大家这个杂志接收个案时要求伦理审查的文件吗？没看懂那个伦理声明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Fri Nov 17 22:29:24 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=920416, encodeId=b9f4920416b8, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：乳腺;甲状腺 经验分享：11月投的 case ,1月后大修，10天后小修，1月初就接收了，很快的杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Wed Jan 27 20:28:28 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896143, encodeId=ae2e89614352, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:53:02 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237427, encodeId=0d2d123e427b0, content=请问接收后多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a256588607, createdName=ms1000000019437335, createdTime=Mon Aug 08 19:05:31 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219178, encodeId=87e712191e8d5, content=偏重的研究方向：甲状腺 经验分享：投稿后awaiting assignment已经半个月了，这个正常吗🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9278140959, createdName=ms3000001761424859, createdTime=Thu May 12 22:06:08 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249421, encodeId=6103124942192, content=审稿前要求提交单位介绍信，请问一定要单位介绍信么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6c55203493, createdName=14744327m60暂无昵称, createdTime=Fri Sep 16 22:53:57 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896130, encodeId=7447896130cf, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:1350.0 偏重的研究方向：临床;回顾性研究 经验分享：今年投了3篇，已经接收了2篇。还有一篇在外审。第一篇是2020.2.9投稿。2020.5.6审稿完，意见是大修，9天后修回。之后的一个月经历了2次小修，主要是填写Reporting Checklist，Data Sharing Statement和STROBE。2020.7.22接收，1天后交版面费1350刀。2周后proof。8月中旬Publish Ahead of Print。10月31日正式发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af391636253, createdName=tangshicong, createdTime=Sun Nov 01 23:02:25 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067301, encodeId=e0d4106e301d5, content=投稿命中率:50.0 经验分享：8-26投稿，8-31返回要上传STROBE_Checklist，9-2上传后10-21修回，5个审稿人，审稿非常仔细，11-5接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=54721606344, createdName=taoyuan2714, createdTime=Fri Nov 05 15:15:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002947, encodeId=a856100294e78, content=7天了还awaiting assignment，这个一般多久决定送不送外审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/11/db1fcba52a5c1ca5a1ed83e1a64d1323.jpg, createdBy=67901701744, createdName=documenta r y, createdTime=Tue Jul 27 10:31:22 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1111845, encodeId=895711118453f, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 Mia

qPCR的结果如何处理？

44 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务